Protection role of GnRH antagonist on cisplatin infertility side effects

Pharmaceutical Sciences

Volumn 19, Issue 2, 2013, Pages 45-51

  Rashtbar, Mortoza ^a   Mohammadnejad, Daryoush ^b   Elahi, Ali Abed ^b   Roushandeh, Amaneh Mohammadi ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Cetrorelix; Cisplatin; Testis

Indexed keywords

CETRORELIX; CISPLATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; GERM LAYER; HISTOLOGY; MALE; MALE INFERTILITY; MORPHOLOGY; MOUSE; NONHUMAN; SEMINIFEROUS TUBULE; SERTOLI CELL; SPERMATOGENESIS; SPERMATOGONIUM;

EID: 84904025213     PISSN: 1735403X     EISSN: 23832886     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Mohammadnejad D, Rad SJ, Roshangar L, Karimpor M, Ghanbari AA, Azami A, et al. Effect of Thiotepa on mice Spermatogenesis using light and electronic microscope. PJBS 2008; 15: 1929-34. (Pubitemid 352837372)
2. Tohda A, Matsumiya K, Tadokoro Y, Yomogida K, Miyagawa Y, Dohmae K, et al. Testostrone supppresses spermatogenesis in juvenile spermatogonial depletion (jsd)mice. Biol Reprod 2001; 65(2): 532-7. (Pubitemid 32702318)
3. Meistrich ML. Hormonal stimulation of the recovery of spermatogenesis following chemo-or radiotherapy. APMIS 1998; 106(1): 37-46. (Pubitemid 28123337)
4. Spermon JR, Ramos L, Wetzels AMM, Sweep CGJ, Braat DDM, Kiemeney LALM, et al. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Hum Reprod 2006; 21(7): 1781-6. (Pubitemid 44028250)
5. Helm CW, States JC. Enhancing the efficacy of cisplatin in ovarian cancer treatment could Arsenic have a role. Ovarian Res 2009; 14(2): 2.
6. Kazumasa N, Yutaka N, Masaaki K, Shunichi N, Takahiko S, Akira Y, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002; 346(2): 85-91.
7. Seaman F, Sawhney P, Giammona CJ, Richburg JH. Cisplatin-induced pulse of germ cell apoptosis precedes long-term elevated apoptotic rates in C57/BL/6 mouse testis. Apoptosis 2003; 8: 101-8. (Pubitemid 36133143)
8. Velasquez WS, Cabanillas F, Salvador P, Mclaughlin P, fridrik M, Tucker S, et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-c and dexamethasone. DHAP 1988; 71(1): 117-22. (Pubitemid 18050400)
9. Sawhney P, Giammona CJ, Meistrich ML, Richburg JH. Cisplatin-induced long-term failure of spermatogenesis in adult C57/Bl/6J mice. J Androl 2005; 26(1): 136-45. (Pubitemid 39665287)
10. Aminsharifi A, Shakeri S, Ariafar A, Moeinjahromi B, Kumar PV, Karbalaeedoost S. Preventive role of exogenous testosterone on cisplatin-induced gonadal toxicity: an experimental placebo-controlled prospective trial. Fertil Steril 2010; 93(5): 1388-93.
11. Turk G, Atessahin A, Sonmez M, Yuce A, Ceribasi AO. Lycopene protects against cyclosporine A-induced testicular toxicity in rats. Theriogenology 2007; 67(4): 778-85. (Pubitemid 46161743)
12. Bar-Shira Maymon B, Yogev L, Marks A, Hauser R, Botchan A. Sertoli cell inactivation damage to the human testis after cancer chemotherapy. Fertil Stril 2004; 81(5): 1391-4. (Pubitemid 38609329)
13. Roberts R. Apoptosis in toxicology. London: Taylor and Francies; 2000.
14. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrisons Principles of Internal. Medicine. 16th ed. New York: McGraw Hill, Medical Publishing Division; 2005.
15. Bibin Bibin A, Tatwei T, Ishii M, Mohammad A, Yoshiakira k. An ultrastructural study on cytotoxic effect of mono (2-ethlyhexyl) phthalate (MEHP) on testes in Shiba goat in vitro. J Vet Sci 2004; 5(3): 235-40.
16. Bakalska M, Atanassova N, Koeva Y, Nikolov B, Davidoff M. Induction of male germ cell apoptosis by testosterone withdrawal after ethane dimethanesulfonate treatment in adult rats. Endocr Regul 2004; 38(3): 103-10. (Pubitemid 41094894)
17. Habermehl D, Kammerer B, Handrick R, Eldh T, Gruber Ch. Proapoptotic activity of ukrain is mitochondrial death pathway. BMC Cancer 2006; 6(1): 14-41.
18. Mi h, Dionisios Ch, Mirja N, Martti P, Staffan E. Doxorubicin induces apoptosis in germ line stem cells in the immature rat testis and amifostin can not protect against this cytotoxicity. Cancer Res 2005; 65(21): 9999-10005.
19. Köberle B, Tomicic M, Usanova S, Kaina B. Cisplatin resistance preclinical findings and clinical implications. Molecul Cancer 2010; 9: 248.
20. Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet 1981; 1(8230): 1132-4. (Pubitemid 11105800)
21. Behre HM, Nashan D, Hubert W, Nieschlag E. Depot Gonadotropin releasing hormone against blunts the androgen induced suppression of spermatogenesis in a clinical trail of male contraception. J Clinic Endocrinol Metabol 1992; 74(1): 84-90.
22. Meistrich ML, Wilson G, Shuttlesworth G, Huhtaniemi I, Reissmann T. GnRH agonists and antagonists stimulate recovery of fertility in irradiated LBNF1 rats. J Androl 2001; 22(5): 809-17. (Pubitemid 32781270)
23. Meistrich ML, Parchuri N, Wilson G, Kurdogluy B, Kangasniemi M. Hormonal protection from cychlophosphamide induced inactivation of rat stem spermatogonia. J Androl 1995; 16(4): 334-1.
24. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005 (34): 12-7.
25. Cook T, Sheridan WP. Development of GnRH antagonists for prostate cancer: new approaches to treatment. Oncologist 2000; 5(2): 162-8. (Pubitemid 30238236)
26. Tevor AJ, Katzung BG, Masters SB. Katzung and Trevoor's Pharmacology. 6th ed. Philadelphia: Mc Graw Hill; 2002.
27. Andreson P, Knoben JE, Troutman WG. Handbook of Clinical Data. 10th ed. New York: Mc Grow Hill; 2002.
28. Grundker C, Schlotawa L, Viereck V, Eick N, Horst A, Kairies B. Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor. Europ J Endocrinol 2004; 151(1): 141-9. (Pubitemid 39117377)
29. Sieniawski M, Reineke T, Nogova L, Josting A, Pfistner B. Fertility in male patients with advance Hodgkin Lymphoma treated with BEACOPP: areport of the German Hodgkin study group. Blood 2008; 111(1): 71-6.
30. Endo F, Manabe F, Takeshima H, Akaza H. Protecting spermatogouia from apoptosis induce by doxorubicin using the Luteinizing hormone releasing hormone analog leuprorelin. Int J Virol 2003; 10: 72-9.
31. Rivkess SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induce gonadal damage. JAMA 1988; 259: 2121-5.
32. Chapman RM, Sutcliffe SB, Ress LH, Edward CR, Malpas JS. Cyclical combination chemotherapy and gonadal function, Retrospective study in males. Lancet 1979; 1: 285-9. (Pubitemid 9104603)
33. Whitehead E, Shalet SM, Blacklege G, Todd I, Crowther D. The effect of Hodgkins disease and combination chemotherapy on gonadal function in the adult male. Cancer 1982; 49: 418-22. (Pubitemid 12213436)
34. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O. Gonadal Toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncology 1985; 21: 601-5. (Pubitemid 15116991)
35. Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediator Oncology 1996; 27: 74-8. (Pubitemid 26198772)
36. Charak BS, Gupta R, Mandrekar P, Sheth NA, Banavali SD. Testicular dysfunction after cyclosphamide vincristine procarbazine prednisolne chemotherapy for advanced Hodgkin's disease. Along follow up study. Cancer 1990; 65: 1903-6. (Pubitemid 20147625)
37. Print CG, Loveland KL. Germ Cell Suicide: new insight in to apoptosis during spermatogenesis. Bio Essay 2000; 22: 423-30. (Pubitemid 30308268)
38. Francavilla S, D'abrizio P, Cordeschi G, Pelliccione F, Necozione S, Ulisse S, et al. Fas expression correlates with human germ cell degeneration in meiotic and post-meiotic arrest of spermatogenesis. Mol Hum Reprod 2002; 8(3): 213-20. (Pubitemid 34196347)
39. Brinkworth MH, Nieschlag E. Association of cychlophosphamide induced male mediated, foetal abnormalities with reduced paternal germ cell apoptosis. Mutat Res 2000; 447: 149-54. (Pubitemid 30177161)
40. Giri A, Khynriam D, Prasad SB. Vitamin C mediated protection on cisplatin induced mutagenicity in mice. Mutat Res 1998; 421: 139-48. (Pubitemid 28511312)
41. Bieber AM, Marcon L, Hales BF, Robaire B. Effects of chemoth apeutic agents for testicular cancer on the male rat reproduct system, spermatozoa, and fertility. J Androl 2006; 27: 189-200.
42. Da Cunha MF, Meistrich ML, Nader S. Absence of testicular protection by a gonadotropin releasing hormone analog against cyclophosphospamide-induced testicular cytotoxicity in the mouse. Cancer Res 1987; 47: 1093-7. (Pubitemid 17027935)
43. Udagawa K, Ogawa T, Watanabe T, Yumura Y, Takeda M, Hosaka M. GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage. Int J Urol 2001; 8: 615-22. (Pubitemid 34017149)
44. Shetty G, Meistrich ML. Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr 2005 (34): 36-9.
45. Meistrich ML, Wilson G, Huhtaniemi I. Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis. Cancer Res 1999; 59: 3557-60. (Pubitemid 29381851)
46. Shetty G, Wilson G, Huhtaniemi I, Shuttlesworth GA, Reissmann T, Meistrich ML. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Endocrinol 2000; 141: 1735-45. (Pubitemid 32274404)
47. Jens E, Bhavika J, Scott DH, Stefan S. Aging does not affect spermatogenic recovery after experimentally induced injury in mice. Reproduction 2007; 133: 75-83.
48. Pelletier G, Labrie C, Labrie F. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. J Endocrinol 2000; 165(2): 359-70. (Pubitemid 30341085)
49. Maekawa M, Kamimura K, Nagano T. Peritubular myoid cells in the testis: their structure and function. Arch Histol Cytol 1996; 59(1): 1-13.
50. Virtanen I, Kallojoki M, Narvanen O. Peritubular myoid cells of human and rat testis are smooth muscle cells that contain desmin-tupe intermediate filaments. J Anat Res 1986; 215(1): 10-20. (Pubitemid 16051554)
51. Aich S, Manna CK. Histo physiological changes of the testicular tissue due to busulphan administration in the wild Indian. Acta Biol Hung 2001; 52(1): 105-16. (Pubitemid 32459203)
52. Shapiro E, Huang H, Masch RJ, Mcfadden DE, Wu XR. Immunolocalization of androgen receptor and estrogen receptors alpha and beta in human fetal testis and epididymis. J Urol 2005; 174(4): 1695-8. (Pubitemid 41318665)
53. Veccino P, Uranga J, Arechaga J. Suppression of spermatologensis for cell transplantation in adult mice. Protoplasma 2001; 217(4): 191-8. (Pubitemid 32657035)
54. Janes GF, Pomerantz DK. The effect of prenatal treatment with busulfan on in vitro androgen production by testes from rats of various ages. Can J physiol Pharmacol 1985; 63(9): 1155-8. (Pubitemid 16228544)
55. Boujrad N, Hochereau-De Reviers MT, Kamtchouing P, Perreau C, Carreau S. Evolution of somatic and germ cell populations after busulfan treatment in utero or neonatal cryptorchidism in the rat. Andrologia 1995; 27(4): 223-8.
56. Gosh S, Bartke A, Grasso P, Reichert LR, Russel LD. Structural manifestation of the rat sertoli cells to hypophysectomy: correlative morphometric and endocrine study. Endocrinol 1992; 131(1): 485-97.
57. Schulz RW, Menting S, Bogerd J, Franca LR, Vilela DA, Godinho HP. Sertoli cell proliferation in the adult testis-evidence from two fish species belonging to different orders. Biol Reprod 2005; 73(5): 891-8. (Pubitemid 41507491)
58. Nanomura M, Okada K, Hida S, Yoshid O. Does a gonadotropin releasing hormone analogue prevent cisplatin - induced spermatogenic impairment? An experimental study in the mouse. Urol Res 1991; 19: 135-40.
59. Meistrich ML, Shetty G. Inhibition of spermatogonial differentiation by testosterone. J Androl 2003; 24(2): 135-48.
60. Hild SA, Meistrich ML, Blye RP, Reel JR. Lupron depot prevention of antispernatogenic/antifertility activity of the indenopyridine, CDB-4022 in the rat. Biol Reprod 2001; 65: 165-72. (Pubitemid 32574796)
61. Shetty G, Wilson G, Hardy MP, Niu E, Huhtaniemi I, Meistrich ML. Inhibition of recovery of spermatogenesis in irradiated rats by different androgens. Endocrinol 2002; 143: 3385-96. (Pubitemid 34925713)
62. Meistrich ML, Shetty G. Inhibition of spermatogonial differentiation by testosterone. J Androl 2003; 24(2): 135-48.